Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2 study of PDNO infusion for pulmonary hypertension after cardiopulmonary bypass surgery
2021-005032-30Phase 2Completed
- Sponsor
- Attgeno AB
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of PDNO in pulmonary hypertension (PH), sponsored by Attgeno AB. Started Dec 2021; status: completed.
02
Drugs
PDNO
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2021-005032-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005032-30.